APA (7th ed.) Citation

Hara, H., Katsumata, R., Yoshinaga, A., Amano, K., Ishii, H., Onodera, K., . . . Sakita, S. (2026). Autopsy‐Proven Immune‐Mediated Hepatitis With Rapid Liver Atrophy Despite Minimal Aminotransferase Elevation After Durvalumab Plus Tremelimumab Therapy for Hepatocellular Carcinoma: A Case Report. Clinical Case Reports, 14(6), 1. https://doi.org/10.1002/ccr3.72806

Chicago Style (17th ed.) Citation

Hara, Hidenobu, et al. "Autopsy‐Proven Immune‐Mediated Hepatitis With Rapid Liver Atrophy Despite Minimal Aminotransferase Elevation After Durvalumab Plus Tremelimumab Therapy for Hepatocellular Carcinoma: A Case Report." Clinical Case Reports 14, no. 6 (2026): 1. https://doi.org/10.1002/ccr3.72806.

MLA (9th ed.) Citation

Hara, Hidenobu, et al. "Autopsy‐Proven Immune‐Mediated Hepatitis With Rapid Liver Atrophy Despite Minimal Aminotransferase Elevation After Durvalumab Plus Tremelimumab Therapy for Hepatocellular Carcinoma: A Case Report." Clinical Case Reports, vol. 14, no. 6, 2026, p. 1, https://doi.org/10.1002/ccr3.72806.